Recent Finacing
Recent Raise
AAVLife is a Paris-registered gene-therapy company developing AAV-mediated frataxin gene delivery for Friedreich’s ataxia, conducting preclinical dosing and administration studies and preparing for clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors